Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib for Airway Plexiform Neurofibromas in Children
NCT03688568Phase 2Withdrawn
- Sponsor
- Indiana University
- Start
- Sep 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in plexiform neurofibroma (PN), sponsored by Indiana University. Planned start Sep 2018; status: withdrawn.
02
Drugs
03
Conditions
plexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT03688568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03688568.